Qube Research & Technologies LTD Genfit S.A. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding GNFT
# of Institutions
6Shares Held
29.3KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny166KShares$687,1280.0% of portfolio
-
Morgan Stanley New York, NY34.7KShares$143,3930.0% of portfolio
-
Ubs Group Ag3.05KShares$12,5880.0% of portfolio
-
Rhumbline Advisers Boston, MA678Shares$2,8000.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P7266Shares$1,0980.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $206M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...